Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

No quotes available
-- EUR   0.00%
06/03 3SBIO INC. : (01530) says ITP drug get clinical trial approval
05/20 3SBIO INC. : (01530) withdraws breast cancer drug application
03/04 3SBIO : Bought CNY3.9bn Shares in CPGJ
SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD531993Chairman, President & Chief Executive Officer
Wei hong Xiao-2016Chief Operating Officer
Bo Tan, MBA432009Chief Financial Officer & Executive Director
Dong Mei Su, PhD452012Executive Director
Bin Huang, MBA551993Executive Director & Vice President
Dong Liu, MBA432014Non-Executive Director
Dong LV, PhD412014Non-Executive Director
Tian Ruo Pu, MBA472014Independent Non-Executive Director
David R. Parkinson MD, PhD662014Independent Non-Executive Director
Jun Ma, PhD532014Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,515,313,570 935,673,010 37.2% 0 0.0% 37.2%
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 712,258,360 28.3%
Jing Lou, MD, PhD 599,367,030 23.8%
Bo Tan, MBA 116,849,920 4.65%
Dan Lou 62,001,010 2.46%
HSBC Global Asset Management (Hong Kong) Ltd. 41,551,500 1.65%
Bin Huang, MBA 33,919,350 1.35%
Dong Mei Su, PhD 26,403,630 1.05%
Allianz Global Investors Asia Pacific Ltd. 25,136,500 1.00%
BlackRock Fund Advisors 17,674,000 0.70%
BlackRock Investment Management (UK) Ltd. 17,569,677 0.70%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
CSL LIMITED
ALEXION PHARMACEU..
GRIFOLS SA
CHONGQING ZHIFEI ..
JIANGXI BOYA BIO-..
3SBIO INC
BEIJING TIANTAN B..
ABCAM PLC
PROMETIC LIFE SCI..
STAIDSON (BEIJING..
-
HUGEL INC
ZHEJIANG WOLWO BI..
BIOTEST AG
PHARMA MAR SA
VITAE PHARMACEUTI..
ESSEX BIO-TECHNOL..
-
REPROCELL INCORPO..
-
CHEMOCENTRYX INC
ALTEOGEN INC
-
PHYTOHEALTH CORP
-
Sector Pharmaceuticals
3SBio Inc. (ADR) : Connections
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Shenzhen Baishitong Technology Development Co., Ltd.
Hong Kong Sansheng Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Taizhou Huan Sheng Investment Management Co., Ltd.
Collected Mind Ltd.
Ample Harvest Investments Ltd.
Liaoning Sunshine Science & Technology Development Co. Ltd.
CITIC Industrial Investment Group Corp. Ltd.
UTStarcom, Inc.
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Shenyang Sunshine Pharmaceutical Co. Ltd.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
Tocagen, Inc.
Zyngenia, Inc.
Beingmate Group Co. Ltd.
Excel Partner Holdings Ltd.
CFA Institute
The Multiple Myeloma Research Foundation, Inc.
Company contact information
3SBio, Inc.
Shenyang Economy & Technology Dev
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.2538.6000
Fax : +86.24.2581.1821
Web : www.3sbio.com
© 2016 People , Fundamentals and Ownership